Gray Michael insider trades
Gray Michael has filed 8 Form 4s with the SEC that we hold, for Upstream Bio, Inc. (UPB) (CFO and COO) and Enliven Therapeutics, Inc. (IMRA) (CFO & COO). Across all of them we count 0 purchases worth $0 and 5 sales worth $77.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($17.8K). The largest single trade was a sale of 9,856 shares of Enliven Therapeutics, Inc. worth $46.0K, dated 2023-02-22. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-02-01 and the latest 2026-09-17.
Upstream Bio, Inc. (UPB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-16 | S, sale reported on Form 4 | 852 | $7.9K | 2026-03-17 |
| 2026-06-16 | S, sale reported on Form 4 | 853 | $5.2K | 2026-06-17 |
| 2026-09-16 | S, sale reported on Form 4 | 853 | $4.7K | 2026-09-17 |
Enliven Therapeutics, Inc. (IMRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-01-30 | S, sale reported on Form 4 | 3,596 | $14.1K | 2023-02-01 |
| 2023-02-22 | S, sale reported on Form 4 | 9,856 | $46.0K | 2023-02-22 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1271411) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms